Featured
-
-
Original Article
| Open AccessOverexpression of a glucokinase point mutant in the treatment of diabetes mellitus
- G Lu
- , X Teng
- & H Xiong
-
Original Article |
Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist
- A Banga
- , L V Greder
- & J M W Slack
-
Original Article |
Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice
- S Vasu
- , R C Moffett
- & P R Flatt
-
Original Article |
Matrix metalloproteinase-inspired suicidal treatments of diabetic ulcers with siRNA-decorated nanofibrous meshes
- H S Kim
- & H S Yoo
-
Original Article |
Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element
- Z Wu
- , M Mata
- & D J Fink
-
Original Article |
Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes
- M Jean
- , M Alameh
- & A Merzouki
-
-
Original Article |
Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector
- S H Choi
- & H C Lee
-
Original Article |
Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy
- S Chen
- , M Shimoda
- & P A Grayburn
-
Original Article |
Functional recovery of diabetic mouse hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO-signaling network
- I Lekli
- , S Mukherjee
- & D K Das
-
Original Article |
Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy
- N K F Chen
- , S Y Tan
- & O L Kon